Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 7/2016

19.08.2016 | ORIGINAL ARTICLE

Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution

verfasst von: Jishu Wei, Xinchun Liu, Junli Wu, Wenbin Xu, Wentao Gao, Kuirong Jiang, Zhihong Zhang, Yi Miao

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to evaluate the diagnosis and surgical management of insulinomas in a single-center setting.

Methods

Demographic details, clinical presentation, preoperative diagnosis, surgical strategy, and outcomes of 33 consecutive patients who underwent surgery for insulinoma were analyzed retrospectively.

Results

The median time from the first onset of symptoms to diagnosis was 24 months (range 3 days to 50 years). All cases presented with Whipple’s triad and had a fasting insulin to glucose ratio higher than 0.33. The preoperative detection rates of transabdominal ultrasonography, CT, MRI, and EUS were 22 % (2/9), 72 % (23/32), 75 % (9/12), and 80 % (4/5), respectively. Intraoperative manual palpation localized all cases. Enucleation was performed in 58 % of cases (19/33), partial pancreatic resection in 39 % (13/33), and enucleation plus partial resection in 3 % (1/33). Pancreatic fistula was the most common complication and occurred in 15 patients (45 %), including seven grade A, five grade B, and three grade C fistulas. There was no mortality. When compared with partial pancreatectomy, enucleation held a significant advantage in operative time and operative bleeding, with no significant differences in demographic data and postoperative complications. During a median follow-up period of 32 months, two patients were lost to follow-up and the remaining 31 patients were without evidence of recurrence.

Conclusions

A fasting insulin release index larger than 0.3 is a reliable indicator for the diagnosis of insulinoma. Intraoperative palpation by an experienced surgeon can effectively complement an uncertain preoperative localization. Compared with partial pancreatic resection, enucleation showed significant benefit in terms of intraoperative blood loss and operation time.
Literatur
1.
Zurück zum Zitat Service FJ, McMahon MM, O'Brien PC, Ballard DJ (1991) Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66(7):711–719CrossRefPubMed Service FJ, McMahon MM, O'Brien PC, Ballard DJ (1991) Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66(7):711–719CrossRefPubMed
2.
Zurück zum Zitat Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, Clark OH (1998) Insulinoma—experience from 1950 to 1995. West J Med 169(2):98–104PubMedPubMedCentral Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, Clark OH (1998) Insulinoma—experience from 1950 to 1995. West J Med 169(2):98–104PubMedPubMedCentral
3.
Zurück zum Zitat Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM (2008) Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer 15(2):409–427CrossRefPubMedPubMedCentral Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM (2008) Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer 15(2):409–427CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Ito T, Igarashi H, Jensen RT (2012) Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol 26(6):737–753CrossRefPubMedPubMedCentral Ito T, Igarashi H, Jensen RT (2012) Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol 26(6):737–753CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Oberg K, Eriksson B (2005) Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 19(5):753–781CrossRefPubMed Oberg K, Eriksson B (2005) Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 19(5):753–781CrossRefPubMed
6.
Zurück zum Zitat Sotoudehmanesh R, Hedayat A, Shirazian N, Shahraeeni S, Ainechi S, Zeinali F, Kolahdoozan S (2007) Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine 31(3):238–241CrossRefPubMed Sotoudehmanesh R, Hedayat A, Shirazian N, Shahraeeni S, Ainechi S, Zeinali F, Kolahdoozan S (2007) Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine 31(3):238–241CrossRefPubMed
7.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M, International Study Group on Pancreatic Fistula Definition (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138(1):8–13CrossRefPubMed Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M, International Study Group on Pancreatic Fistula Definition (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138(1):8–13CrossRefPubMed
8.
Zurück zum Zitat Roth J, Komminoth P, Heitz PU (1995) Topographic abnormalities of proinsulin to insulin conversion in functioning human insulinomas. Comparison of immunoelectron microscopic and clinical data. Am J Pathol 147(2):489–502PubMedPubMedCentral Roth J, Komminoth P, Heitz PU (1995) Topographic abnormalities of proinsulin to insulin conversion in functioning human insulinomas. Comparison of immunoelectron microscopic and clinical data. Am J Pathol 147(2):489–502PubMedPubMedCentral
9.
Zurück zum Zitat Sharma P, Sharma S, Kalhan S, Singh BP (2014) Insulinoma: a comprehensive summary of two cases. J Clin Diagn Res 8(9):FD05–FD06PubMedPubMedCentral Sharma P, Sharma S, Kalhan S, Singh BP (2014) Insulinoma: a comprehensive summary of two cases. J Clin Diagn Res 8(9):FD05–FD06PubMedPubMedCentral
10.
Zurück zum Zitat Mirancea GV, Morosanu AM, Carniciu S, Dima S, Bacalbasa N, Popescu I, Ionescu-Tirgoviste C, Mirancea N (2014) Relevant infrastructural alterations in a pancreatic neuroendocrine tumor: an insulinoma case. Romanian J Morphol Embryol 55(2 Suppl):659–668 Mirancea GV, Morosanu AM, Carniciu S, Dima S, Bacalbasa N, Popescu I, Ionescu-Tirgoviste C, Mirancea N (2014) Relevant infrastructural alterations in a pancreatic neuroendocrine tumor: an insulinoma case. Romanian J Morphol Embryol 55(2 Suppl):659–668
11.
Zurück zum Zitat Ielpo B, Caruso R, Ferri V, Quijano Y, Duran H, Diaz E, Fabra I, Puga R, Oliva C, Olivares S, Vicente E (2013) Giant pancreatic insulinoma. The bigger the worse? Report of two cases and literature review. Int J Surg Case Rep 4(3):265–268CrossRefPubMed Ielpo B, Caruso R, Ferri V, Quijano Y, Duran H, Diaz E, Fabra I, Puga R, Oliva C, Olivares S, Vicente E (2013) Giant pancreatic insulinoma. The bigger the worse? Report of two cases and literature review. Int J Surg Case Rep 4(3):265–268CrossRefPubMed
12.
Zurück zum Zitat Bright E, Garcea G, Ong SL, Madira W, Berry DP, Dennison AR (2008) An unusual case of concurrent insulinoma and nesidioblastosis. JOP 9(5):649–653PubMed Bright E, Garcea G, Ong SL, Madira W, Berry DP, Dennison AR (2008) An unusual case of concurrent insulinoma and nesidioblastosis. JOP 9(5):649–653PubMed
13.
Zurück zum Zitat Tongson-Ignacio JE, Honda SA, Bhagavan NV (2005) Insulinoma, a rare neuroendocrine tumor: a case report. Hawaii Med J 64(1):9–11PubMed Tongson-Ignacio JE, Honda SA, Bhagavan NV (2005) Insulinoma, a rare neuroendocrine tumor: a case report. Hawaii Med J 64(1):9–11PubMed
14.
Zurück zum Zitat Mittendorf EA, Liu YC, McHenry CR (2005) Giant insulinoma: case report and review of the literature. J Clin Endocrinol Metab 90(1):575–580CrossRefPubMed Mittendorf EA, Liu YC, McHenry CR (2005) Giant insulinoma: case report and review of the literature. J Clin Endocrinol Metab 90(1):575–580CrossRefPubMed
15.
Zurück zum Zitat Roland CL, Lo CY, Miller BS, Holt S, Nwariaku FE (2008) Surgical approach and perioperative complications determine short-term outcomes in patients with insulinoma: results of a bi-institutional study. Ann Surg Oncol 15(12):3532–3537CrossRefPubMed Roland CL, Lo CY, Miller BS, Holt S, Nwariaku FE (2008) Surgical approach and perioperative complications determine short-term outcomes in patients with insulinoma: results of a bi-institutional study. Ann Surg Oncol 15(12):3532–3537CrossRefPubMed
16.
Zurück zum Zitat Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G (2013) Risk factors for the occurrence of insulinoma: a case-control study. Hepatobiliary Pancreat Dis Int 12(3):324–328CrossRefPubMed Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G (2013) Risk factors for the occurrence of insulinoma: a case-control study. Hepatobiliary Pancreat Dis Int 12(3):324–328CrossRefPubMed
17.
Zurück zum Zitat Zhao YP, Zhan HX, Cong L, Zhang TP, Liao Q, Dai MH, Cai LX, Zhu Y (2012) Risk factors for postoperative pancreatic fistula in patients with insulinomas: analysis of 292 consecutive cases. Hepatobiliary Pancreat Dis Int 11(1):102–106CrossRefPubMed Zhao YP, Zhan HX, Cong L, Zhang TP, Liao Q, Dai MH, Cai LX, Zhu Y (2012) Risk factors for postoperative pancreatic fistula in patients with insulinomas: analysis of 292 consecutive cases. Hepatobiliary Pancreat Dis Int 11(1):102–106CrossRefPubMed
18.
Zurück zum Zitat Horvath E, Gozar H, Chira L, Dunca I, Kiss E, Pavai Z (2013) Insulinoma diagnosed as drug-refractory epilepsy in an adolescent boy: a case report. Romanian J Morphol Embryol 54(4):1147–1151 Horvath E, Gozar H, Chira L, Dunca I, Kiss E, Pavai Z (2013) Insulinoma diagnosed as drug-refractory epilepsy in an adolescent boy: a case report. Romanian J Morphol Embryol 54(4):1147–1151
19.
Zurück zum Zitat Louda F, Chadli A, Elaziz S, Elghomari H, Farouqi A (2013) Malignant insulinoma misdiagnosed and treated as epilepsy. Ann Endocrinol (Paris) 74(1):53–55CrossRef Louda F, Chadli A, Elaziz S, Elghomari H, Farouqi A (2013) Malignant insulinoma misdiagnosed and treated as epilepsy. Ann Endocrinol (Paris) 74(1):53–55CrossRef
20.
Zurück zum Zitat Correia P, Panchani R, Ranjan R, Agrawal C (2012) Insulinoma presenting as refractory seizure disorder. F1000Res 1:15PubMedPubMedCentral Correia P, Panchani R, Ranjan R, Agrawal C (2012) Insulinoma presenting as refractory seizure disorder. F1000Res 1:15PubMedPubMedCentral
21.
Zurück zum Zitat Bonato FT, Coelho JC, Petruzzielo A, Matias JE, Ferreira GA (2012) Surgical treatment of pancreatic insulinomas. Arq Bras Cir Dig 25(2):101–104CrossRefPubMed Bonato FT, Coelho JC, Petruzzielo A, Matias JE, Ferreira GA (2012) Surgical treatment of pancreatic insulinomas. Arq Bras Cir Dig 25(2):101–104CrossRefPubMed
22.
Zurück zum Zitat Graves TD, Gandhi S, Smith SJ, Sisodiya SM, Conway GS (2004) Misdiagnosis of seizures: insulinoma presenting as adult-onset seizure disorder. J Neurol Neurosurg Psychiatry 75(8):1091–1092CrossRefPubMedPubMedCentral Graves TD, Gandhi S, Smith SJ, Sisodiya SM, Conway GS (2004) Misdiagnosis of seizures: insulinoma presenting as adult-onset seizure disorder. J Neurol Neurosurg Psychiatry 75(8):1091–1092CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Goh BK, Ooi LL, Cheow PC, Tan YM, Ong HS, Chung YF, Chow PK, Wong WK, Soo KC (2009) Accurate preoperative localization of insulinomas avoids the need for blind resection and reoperation: analysis of a single institution experience with 17 surgically treated tumors over 19 years. J Gastrointest Sur 13:1071–1077CrossRef Goh BK, Ooi LL, Cheow PC, Tan YM, Ong HS, Chung YF, Chow PK, Wong WK, Soo KC (2009) Accurate preoperative localization of insulinomas avoids the need for blind resection and reoperation: analysis of a single institution experience with 17 surgically treated tumors over 19 years. J Gastrointest Sur 13:1071–1077CrossRef
24.
Zurück zum Zitat Lo CY, Lam KY, Kung AW, Lam KS, Tung PH, Fan ST (1997) Pancreatic insulinomas. A 15-year experience. Arch Surg 132:926–930CrossRefPubMed Lo CY, Lam KY, Kung AW, Lam KS, Tung PH, Fan ST (1997) Pancreatic insulinomas. A 15-year experience. Arch Surg 132:926–930CrossRefPubMed
25.
Zurück zum Zitat McAuley G, Delaney H, Colville J, Lyburn I, Worsley D, Govender P, Torreggiani WC (2005) Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol 60(10):1039–1050CrossRefPubMed McAuley G, Delaney H, Colville J, Lyburn I, Worsley D, Govender P, Torreggiani WC (2005) Multimodality preoperative imaging of pancreatic insulinomas. Clin Radiol 60(10):1039–1050CrossRefPubMed
26.
Zurück zum Zitat Anakal MG, Kalra P, Dharmalingam M, Indushekhar S, Rao V, Prasanna Kumar KM (2014) Insulinoma case series: experience of a tertiary care center. Indian J Endocrinol Metab 18(6):858–862CrossRefPubMedPubMedCentral Anakal MG, Kalra P, Dharmalingam M, Indushekhar S, Rao V, Prasanna Kumar KM (2014) Insulinoma case series: experience of a tertiary care center. Indian J Endocrinol Metab 18(6):858–862CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Callacondo D, Arenas JL, Ganoza AJ, Rojas-Camayo J, Quesada-Olarte J, Robledo H (2013) Giant insulinoma: a report of 3 cases and review of the literature. Pancreas 42(8):1323–1332CrossRefPubMed Callacondo D, Arenas JL, Ganoza AJ, Rojas-Camayo J, Quesada-Olarte J, Robledo H (2013) Giant insulinoma: a report of 3 cases and review of the literature. Pancreas 42(8):1323–1332CrossRefPubMed
28.
Zurück zum Zitat Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, Kobayashi M, Hanazaki K (2013) Diagnosis and management of insulinoma. World J Gastroenterol 19(6):829–837CrossRefPubMedPubMedCentral Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, Kobayashi M, Hanazaki K (2013) Diagnosis and management of insulinoma. World J Gastroenterol 19(6):829–837CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Mehrabi A, Fischer L, Hafezi M, Dirlewanger A, Grenacher L, Diener MK, Fonouni H, Golriz M, Garoussi C, Fard N, Rahbari NN, Werner J, Buchler MWA (2014) Systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas 43(5):675–686CrossRefPubMed Mehrabi A, Fischer L, Hafezi M, Dirlewanger A, Grenacher L, Diener MK, Fonouni H, Golriz M, Garoussi C, Fard N, Rahbari NN, Werner J, Buchler MWA (2014) Systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas 43(5):675–686CrossRefPubMed
30.
Zurück zum Zitat Ayav A, Bresler L, Brunaud L, Boissel P (2005) Laparoscopic approach for solitary insulinoma: a multicentre study. Langenbeck’s Arch Surg 390(2):134–140CrossRef Ayav A, Bresler L, Brunaud L, Boissel P (2005) Laparoscopic approach for solitary insulinoma: a multicentre study. Langenbeck’s Arch Surg 390(2):134–140CrossRef
31.
Zurück zum Zitat Zhao YP, Zhan HX, Zhang TP, Cong L, Dai MH, Liao Q, Cai LX (2011) Surgical management of patients with insulinomas: result of 292 cases in a single institution. J Surg Oncol 103(2):169–174CrossRefPubMed Zhao YP, Zhan HX, Zhang TP, Cong L, Dai MH, Liao Q, Cai LX (2011) Surgical management of patients with insulinomas: result of 292 cases in a single institution. J Surg Oncol 103(2):169–174CrossRefPubMed
32.
Zurück zum Zitat Balci NC, Semelka RC (2001) Radiologic features of cystic, endocrine and other pancreatic neoplasms. Eur J Radiol 38(2):113–119CrossRefPubMed Balci NC, Semelka RC (2001) Radiologic features of cystic, endocrine and other pancreatic neoplasms. Eur J Radiol 38(2):113–119CrossRefPubMed
33.
Zurück zum Zitat Vinik AI, Delbridge L, Moattari R, Cho K, Thompson N (1991) Transhepatic portal vein catheterization for localization of insulinomas: a ten-year experience. Surgery 109(1):1–11 discussion 111PubMed Vinik AI, Delbridge L, Moattari R, Cho K, Thompson N (1991) Transhepatic portal vein catheterization for localization of insulinomas: a ten-year experience. Surgery 109(1):1–11 discussion 111PubMed
34.
Zurück zum Zitat Hackert T, Hinz U, Fritz S, Strobel O, Schneider L, Hartwig W, Buchler MW, Werner J (2011) Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections. Langenbeck’s Arch Surg 396(8):1197–1203CrossRef Hackert T, Hinz U, Fritz S, Strobel O, Schneider L, Hartwig W, Buchler MW, Werner J (2011) Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections. Langenbeck’s Arch Surg 396(8):1197–1203CrossRef
35.
Zurück zum Zitat Grygiel K, Szmidt J, Jelenska M, Pawlak K (2012) Surgical treatment of hyperinsulinism during the course of pancreatic cancer (insulinoma) —one center experience. Pol Przegl Chir 84(1):31–36PubMed Grygiel K, Szmidt J, Jelenska M, Pawlak K (2012) Surgical treatment of hyperinsulinism during the course of pancreatic cancer (insulinoma) —one center experience. Pol Przegl Chir 84(1):31–36PubMed
36.
Zurück zum Zitat Falconi M, Bettini R, Boninsegna L, Crippa S, Butturini G, Pederzoli P (2006) Surgical strategy in the treatment of pancreatic neuroendocrine tumors. JOP 7(1):150–156PubMed Falconi M, Bettini R, Boninsegna L, Crippa S, Butturini G, Pederzoli P (2006) Surgical strategy in the treatment of pancreatic neuroendocrine tumors. JOP 7(1):150–156PubMed
37.
Zurück zum Zitat Jensen RT, Berna MJ, Bingham DB, Norton JA (2008) Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 113(7 Suppl):1807–1843CrossRefPubMedPubMedCentral Jensen RT, Berna MJ, Bingham DB, Norton JA (2008) Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 113(7 Suppl):1807–1843CrossRefPubMedPubMedCentral
Metadaten
Titel
Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution
verfasst von
Jishu Wei
Xinchun Liu
Junli Wu
Wenbin Xu
Wentao Gao
Kuirong Jiang
Zhihong Zhang
Yi Miao
Publikationsdatum
19.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 7/2016
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-016-1496-y

Weitere Artikel der Ausgabe 7/2016

Langenbeck's Archives of Surgery 7/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.